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Summary 
To study the effect of cell type-restricted hamster PrP 
expression on susceptibility to the hamster scrapie 
agent, we generated transgenic mice using a I kb ham- 
ster cDNA clone containing the 0.76 kb HPrP open 
reading frame under control of the neuron-specific 
enolase promoter, in these mice, expression of HPrP 
was detected only in brain tissue, with highest levels 
found in neurons of the cerebellum, hippocampus, 
thalamus, and cerebral cortex. These transgenic mice 
were susceptible to infection by the 263K strain of 
hamster scrapie with an average incubation period of 
93 days, compared to 72 days in normal hamsters. In 
contrast, nontransgenic mice were not susceptible to 
this agent. These results indicate that neuron-specific 
expression of the 1 kb HPrP minigene including the 
HPrP open-reading frame is sufficient to mediate sus- 
ceptibility to hamster scrapie, and that HPrP expres- 
sion in nonneuronal brain cells is not necessary to 
overcome the TSE species barrier. 
Introduction 
Transmissible spongiform encephalopathies (TSE) are de- 
generative brain diseases that occur naturally in primates 
and ruminants, and include scrapie of sheep, bovine spon- 
giform encephalopathy, and several human diseases such 
as Creutzfeldt-Jakob disease, Kuru, and Gerstmann- 
Str~.ussler-Scheinker syndrome. An important feature of 
TSE diseases is the accumulation in brain of a proteinase 
K-resistant protein, known as PrP-res or PrP s°, which ap- 
pears to be strongly associated with the pathogenic pro- 
cess (Bolton et al., 1982; Prusiner, 1982; Diringer et al., 
1983). PrP-res is posttranslationally derived from a normal 
host proteinase K-sensitive PrP molecule (PrP-sen; Bor- 
chelt et al., 1990; Caughey and Raymond, 1991; Stahl 
et al., 1993) by an as yet undefined mechanism. Brain 
preparations highly enriched for scrapie infectivity contain 
large amounts of PrP-res, but no scrapie-specific nucleic 
acid has been detected (Alper et al., 1978; Hunter, 1979; 
Latarjet, 1979; Dees et al., 1985; Bellinger-Kawahara et 
al., 1987). As a result, it has been suggested that PrP-res 
is the etiologic agent of TSE (Prusiner, 1982). Although the 
precise nature of the causative agent remains unresolved, 
several studies have established an important role for PrP 
in TSE pathogenesis. For example, there is a close linkage 
between the PrP gene and a gene controlling the length 
of the scrapie incubation period in mice and sheep (Carl- 
son et al., 1988; Hunter et al., 1989; Race et al., 1990). 
Also, mutations in the human PrP gene are associated 
with occurrence of familial Creutzfeldt-Jakob disease, 
Gerstmann-Str&ussler-Scheinker syndrome, and Fatal 
Familial Insomnia (Doh-ura et al., 1989; Hsiao et al., 1989, 
1991a, 1991b; Goldgaber et al., 1989; Goldfarb et al., 
1990). In addition, PrP null mice devoid of PrP-sen are 
resistant to experimental scrapie, indicating that expres- 
sion of PrP-sen is an absolute requirement for scrapie 
agent replication and disease induction (Bueler et al., 
1993). 
PrP may also play a critical role in interspecies transmis- 
sion of TSE diseases. Many species show resistance to 
disease induction by TSE agents derived from other spe- 
cies. This resistance or "species barrier" is manifested ei- 
ther by total lack of disease induction or by a prolonged 
incubation period prior to onset of clinical disease. For 
instance, Chandler mouse scrapie can be transmitted to 
Syrian hamsters with an average incubation period of 378 
days, but in mice the incubation period is 120 days (Kim- 
berlin and Walker, 1978; Kimberlin et al., 1987). Con- 
versely, the 263K hamster scrapie strain has a 72 day 
incubation period in Syrian hamsters, but does not cause 
clinical disease in mice. Of particular concern is whether 
or not various strains of TSE in animals can be transmitted 
to humans. Epidemiological studies indicate that transmis- 
sion from scrapie-infected sheep to humans does not oc- 
cur. However, the recent epidemic of bovine spongiform 
encephalopathy in Great Britain has raised worries that 
this apparently new strain of TSE might be infectious to 
humans. 
These concerns have highlighted the importance of un- 
derstanding the basis for species barriers in the transmis- 
sion of TSE. Genetic studies have indicated that the PrP 
genotype strongly influences the host susceptibility to TSE 
agents (Carlson et al., 1986; Hunter et al., 1987; Race et 
al., 1990). Transgenic mice with a 40 kb transgene ex- 
pressing high levels of hamster PrP (HPrP)-sen are sus- 
ceptible to disease when inoculated with the hamster 
scrapie agent, while normal mice are resistant (Scott et 
al., 1989; Prusiner et al., 1990). This suggests that trans- 
mission of scrapie may be dependent on interactions be- 
tween the host PrP-sen and the PrP-res associated with 
the inoculated agent. The importance of direct PrP-sen- 
PrP-res interactions in PrP-res formation has now been 
documented in cell-free reactions (Kocisko et al., 1994, 
1995). Furthermore, interactions between PrP molecules 
from different species have been found to inhibit genera- 
tion of PrP-res in both scrapie-infected cells (Priola et al., 
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1994) and in cell-free systems (Kocisko et al., 1994, 1995), 
and such inhibitory interactions may provide a biochemical 
explanation for the species barrier. 
The normal PrP-sen precursor of PrP-res appears to be 
expressed in a wide variety of cells and tissues (Oesch 
et al., 1985; Caughey et al., 1988; Brown et al., 1990), 
and it is unclear which of these sites might be involved in 
the possible effect of PrP on TSE agent replication and 
PrP-res formation following interspecies transmission. 
TSE agents are known to replicate in both lymphoreticular 
organs and brain, but the precise cell types involved are 
not known. PrP-sen expression has recently been demon- 
strated in astrocytes and ol igodendrocytes (Moser et al., 
1995), and astrocytes have been found to be the earliest 
site of PrP-res accumulation in the brain (Diedrich et al., 
1991). Together, these results argue for the direct involve- 
ment of gila in scrapie agent propagation. However, in 
mouse and hamster brain, high levels of PrP mRNA and 
PrP-sen protein have also been detected in neurons 
(Kretzschmar et al., 1986; Brown et al., 1990; Manson 
et al., 1992, 1994). Therefore, it is unclear whether PrP 
expression in both neurons and astrocytes is critical to 
PrP-res formation. In the present work, we show that 
transgenic mice expressing the hamster PrP (HPrP) gene 
under control of the neuron-specific enolase promoter 
(Forss-Petter et al., 1990) are highly susceptible to the 
hamster scrapie agent. In these mice, HPrP expression 
was found exclusively in neurons and not in glial cells or 
cells within the spleen or lymph nodes. Thus, neuron- 
specific hamster PrP expression was sufficient to abrogate 
the TSE species barrier, and hamster PrP expression in 
lymphoreticular tissues or nonneuronal brain cells includ- 
ing astrocytes was not required to overcome resistance 
of mice to the hamster scrapie agent. Furthermore, be- 
cause the transgene used in these experiments contained 
only I kb of hamster DNA including the open reading frame 
of hamster PrP, the present results demonstrate that sus- 
ceptibility of these transgenic mice to hamster scrapie is 
mediated by the hamster PrP gene itself rather than the 
additional 39 kb of transgene DNA used in previous stud- 
ies (Scott et al., 1989; Prusiner et al., 1990; Westaway et 
al., 1994). 
Results 
Generation of HPrP Transgenic Mice 
To investigate the role of HPrP in the interspecies trans- 
mission of hamster scrapie, two lines of HPrP transgenic 
mice were produced. The Tg52NSE line was derived by 
inoculation of a construct containing the neuron-specific 
enolase (NSE) promotor plus a 1 kb cDNA containing the 
HPrP open reading frame (Figure 1A). A second HPrP 
transgenic line, Tgl0,  was generated with a cosmid vector 
containing the HPrP gene plus 40 kb of flanking DNA 
(Scott et al., 1989). Previously, this cosmid was used to 
generate another line of transgenic mice susceptible to 
hamster scrapie (Scott et al., 1989). Following production 
of transgenic mice by standard techniques, positive 
founder mice were bred to nontransgenic C57BL/10 mice, 
and the transgene was maintained in heterozygous form 
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Figure 1A. Structure of NSE-HPrP Transgene and Predicted mRNA 
(A) 1.0 kb fragment of the hamster PrP (HPrP) cDNA (Robakis etal., 
1986a, 1986b) containing the 762 bp open reading frame (boxed) was 
cloned into the Hindlll site of pNSE-Ex 4, which was generated and 
provided by Dr. Sonja Forss-Petter, Scripps Research Institute, from 
a previously described genomic clone of the rat NSE gene (Forss- 
Petter et al., 1990; Mucke t al., 1994). pNSE-Ex 4 contains 2.8 kb
of rat NSE flanking sequences upstream of the transcriptional start 
of exon 1,54 bp of exon I, a 1.2 kb intron, and 6 bp of exon 2 upstream 
of the unique Hindlll cloning site. Downstream of the Hindlll site is a 
1 kb fragment of SV40 sequence used as a molecular t g for transgenic 
RNA in in situ hybridization studies. The poly A signal is located in 
the middle of the SV40 DNA. The transgene DNA was excised from 
the bacterial plasmid vector, pUC 19, by digestion with Sail, and the 
large Sail fragment shown was purified and used for inoculation of 
mouse cells for generation f transgenic mice. 
(B) Expression of HPrP mRNA in transgenic mouse brain. Polyadeny- 
lated RNA (2 pg) extracted from brain of a normal nontransgenic 
mouse, a Tg52NSE, or a Tgl0 mouse was separated on an agarose/ 
formaldehyde gel, blotted, and hybridized to a 32P-labeled DNA probe 
derived from HPrP. Under the conditions used, this probe hybridizes 
to RNA derived from either mouse PrP (MPrP) or HPrP. The 2.3 kb 
mRNA common to all three lanes represents MPrP mRNA derived 
from the endogenous MPrP gene. The HPrP mRNA derived from TglO 
brain is also present at 2.3 kb. The unique 1.6 kb mRNA band in the 
Tg52NSE lane is derived from the NSE-HPrP construct and is the size 
expected for the fully spliced transcript. 
(C) Western blot detection of HPrP-sen in tissues from a Tg52NSE 
mouse, a Tgl0 mouse, and a normal hamster. Suspensions of various 
tissues were separated on 15% SDS-polyacrylamide electrophoresis 
gels. Proteins were transferred to Immobilon nylon membranes and 
immunoblots performed using antibody 3F4, which recognizes ham- 
ster PrP but not mouse PrP. Blots were developed using the Enhanced 
Chemiluminescence reagent system (Amersham). Immunoreactive 
bands shown represent HPrP-sen. HPrP-sen was detected in all of
the indicated tissues from Tgl0 mice. In Tg52NSE mice, HPrP-sen 
was detected only in brain. Normal hamsters had HPrP-sen in brain, 
heart, lung, and thymus but not in muscle or spleen. Hamster testes 
were not assayed. 
by selection at each breeding cross. By comparative slot 
blot analysis, the transgene copy number was approxi- 
mately 8 for Tg52NSE and 12 for Tg l0  mice (data not 
shown). 
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Figure 2. Expression of HPrP mRNA in Various Brain Regions of Tg52NSE Mice 
Brain sections were processed for in situ hybridization and light microscopy as described in the Experimental Procedures• The probe used was 
from a portion of SV40 sequence unique to the transgene (see Figure 1A). Identical fields were photographed with conventional illumination to 
show histology with hematoxylin and eosin staining ("H and E"; first column) and by dark field illumination (second column) to show the location 
of silver grains (white dots) corresponding to HPrP mRNA. Strong signals were detected in the band of Purkinje cells adjacent to the granular 
layer of the cerebellum, and at higher magnification silver grains were localized over individual Purkinje cells (not shown)• Gra ule cell neurons 
of the cerebellum were also positive, but this was not obvious at the magnification shown here (first row). Regions containing the pyramidal neurons 
of the hippocampus and the neurons of the dentate gyrus were strongly positive (second and third rows), and individual cells i  the adja nt
thalamus were also positive (second row, left panel). Several layers of positive cells were also detected in th  cer bral cortex (fourth ow). 
HPrP mRNA Expression in Brains 
of Transgenic Mice 
To analyze HPrP mRNA expression in the brain of 
transgenic mice, Northern blotting was performed with a 
probe reactive with both mouse and hamster PrP genes. 
Tg52NSE mice expressed a 1.6 kb PrP mRNA band corre- 
sponding to the predicted HPrP transgene in addition to 
the 2.3 kb PrP mRNA band expressed in nontransgenic 
mice (Figure 1B). The intensity of the 1.6 kb HPrP band 
was 4-5 times higher than that of the 2.3 kb endogenous 
mouse PrP band. In contrast, Tg l0  mice containing the 
cosmid HPrP transgene showed no new PrP bands distin- 
guishable from mouse PrP by Northern blotting (Figure 
1B). However, the increased intensity of the band at 2.3 
kb was consistent with expression of a 2.3 kb HPrP mRNA 
from the cosmid transgene. 
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Figure 3. Kinetics of Death of Tg52NSE Mice, Tgl0 Mice, and Non- 
transgenic Mice after Intracerebral Inoculation with Hamster Scrapie 
Strain 263K 
Data are pooled from experiments done at Rocky Mountain Labora- 
tories and Scripps Research Institute (Tg52NSE mice, n = 60; Tgl0 
mice, n = 65; and nontransgenic mice, n = 25). 
HPrP Protein Expression in Transgenic 
Mouse Tissues 
To study tissue specificity of HPrP protein expression, a 
variety of tissues from both HPrP transgenic mouse lines 
and normal hamsters was analyzed by immunoblotting 
using monoclonal antibody 3F4, which has a strong reac-  
tivity for HPrP and no reactivity for mouse PrP (Kascsak 
et al., 1987). In Tg52NSE mice, HPrP protein was detected 
in brain, but not in six other tissues studied (Figure 1C). 
In contrast, Tgl0 mice and normal hamsters expressed 
HPrP protein in a variety of other tissues in addition to 
brain (Figure 1C). Thus, the transgene in Tg52NSE mice 
showed a restricted pattern of expression as expected 
from the use of the neuron-specific enolase promoter 
(Forss-Petter et al., 1990). 
Neuronal Localization of HPrP Expression 
in Tg52NSE Mice 
In situ hybridization was used to study localization of HPrP 
mRNA in Tg52NSE mouse brain. For detection, we used a 
probe from SV40-derived intervening sequences present 
Table 1. Comparison of Clinical Disease Induced by the 263K Strain 
of Hamster Scrapie. 
Transgenic Mice Syrian 
Tg52NSE Tgl0 Hamsters Clinical Data 
Number of animals 60 65 43 
Average interval to death a 93 _+ 8d  248 _+ 64d 72 _ 3d  
Duration of symptoms 1-3 d 30-90 d 10-15 d 
Ataxia + + + 
Tremors - + + 
Paralysis - + 
Stilted gaiP + - - 
Somnolence - - + 
a Mean -+ standard deviation; d, days. Animals were sacrificed when 
clinical condition was near terminal. Nontransgenic mice inoculated 
with hamster 263K scrapie agent showed no signs of disease within 
a normal life span (2 years). 
. Stilted gait was characterized by walking on tiptoes. 
only in the HPrP mRNA of the Tg52NSE mice (Figure 
1A). HPrP mRNA was detected in a variety of neuronal 
populations of the brain. Highest expression was seen in 
Purkinje cells of the cerebellum, neurons of the dentate 
gyrus, and pyramidal neurons of the hippocampus (Figure 
2). Granular layer neurons of the cerebellum, cells in vari- 
ous layers of the cerebral cortex, and cells with large nuclei 
in the dorsal portion of the thalamus also expressed mod- 
erate amounts of HPrP mRNA (Figure 2). These results 
were consistent with neuron-specific expression of the 
HPrP transgene in Tg52NSE mice. 
Further confirmation of neuronal expression of the HPrP 
transgene was achieved using primary hippocampal neu- 
ron cultures and astrocyte cultures. Using monoclonal an- 
tibody 3F4, greater than 90% of neurons from Tg52NSE 
mice had detectable HPrP protein after in vitro culture for 
48 hr. This was observed in 3 out of 5 experiments. In 
contrast, astrocytes cultured from these same mice never 
expressed detectable HPrP (data not shown). 
Susceptibility of Tg52NSE and Tgl0 Mice 
to Hamster Scrapie Agent 
To determine the influence of HPrP expression on suscep- 
tibility to hamster scrapie agent, Tg52NSE, Tgl0, non-Tg 
mice, and hamsters were inoculated with hamster scrapie 
strain 263K. Tg52NSE mice all died between 70 and 118 
days postinoculation, while non-Tg littermates were clini- 
cally normal 400 days postinoculation (Figure 3). Affected 
mice exhibited a 1-3 day clinical course characterized by 
a "stilted" gait, mild ataxia, and inactivity (Table 1). Tgl0 
mice, on the other hand, had a more variable and pro- 
tracted clinical course lasting several weeks or even 
months and died between 80 and 405 days postinoculation 
(Figure 3). The clinical symptoms in Tgl0 mice included 
whole-body tremors, ataxia, and progression to paralysis 
and death (Table 1). In hamsters, clinical symptoms in- 
cluded ataxia, tremor, and somnolence (Table 1). Clini- 
cally ill Tg52NSE mice and Tgl0 mice had easily detect- 
able proteinase K-resistant HPrP and histopathological 
findings typical of scrapie with astrocytosis and spongiosis 
(data not shown). Furthermore, brain homogenates from 
hamster scrapie-infected Tg52NSE and Tgl0 mice 
caused scrapie on reinoculation in hamsters, but not in 
mice (data not shown). In summary, Tg52NSE and Tgl0 
mice were highly susceptible to hamster 263K scrapie 
agent, but both the tempo and symptoms of clinical dis- 
ease were different in the two transgenic strains. 
To determine whether the expression of HPrP would 
modify the pathogenesis of mouse scrapie, Tg52NSE and 
Tgl0 mice were also inoculated with the Chandler strain 
of mouse-adapted scrapie agent. Tg52NSE mice died 
180 + 3 days postinoculation (n = 8), while normal lit- 
termates died 160 __+ 3 days postinoculation (n = 11). 
Tgl0 mice died 201 -+ 4 days postinoculation (n = 17), 
while their normal littermates died 164 _.+ 4 days after 
inoculation (n = 14). Thus, expression of HPrP in both 
Tg52NSE and Tgl0 mice delayed the onset of clinical 
disease induced by the mouse scrapie agent, suggesting 
that expression of HPrP could partially interfere with devel- 
opment of mouse scrapie. 
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Figure 4. Distribution of HPrP-res in Tg52NSE Brain 
Brains from uninfected (A) and hamster scrapie-infected (B-F) Tg52NSE mice were analyzed for HPrP-res by hydrolytic autoclaving and immunostain- 
ing using antibody 3F4. HPrP staining was most intense in thalamic nuclei (B and C) the diagonal band of broca (D) where HPrP was primarily 
located in the neuropil. Perineuronal (arrows) and "beads-on-a-string" (arrowheads) HPrP staining pattern were found in the anterior hypothalamus 
(E). In midbrain nuclei (F), intraneuronal HPrP immunostaining was observed in the cell body (arrow) and proximal axons (arrowhead). Enlarged 
ventricular space in infected mice appeared to be secondary to cortical atrophy, as there was no obvious increased intracranial presence or 
hydrocephalus on gross examination. Bars in (A) and (B), 1 mm; in (C), 100 #m; in (D) and (E), 50 I~m; and in (F), 25 p.m. 
Pattern of HPrP-res Deposition in Transgenic Mice 
The regional and cellular distribution of HPrP-res was de- 
termined by immunocytochemistry using antihamster PrP 
monoclonal antibody 3F4 on brain sections pretreated with 
hydrolytic autoclaving (Kitamoto et al., 1992). This proce- 
dure enhances immunoreactivity of PrP-res and elimi- 
nates detection of PrP-sen. The distribution of HPrP-res 
in brains of Tg52NSE mice infected with hamster scrapie 
was restricted to specific anatomical regions (Figure 4B) 
and was not as widespread as reported for hamsters in- 
fected with this same scrapie strain (DeArmond et al., 
1992). HPrP-res was primarily found in gray matter and 
was rarely detected in white matter tracts. Intense immu- 
nostaining was observed in several thalamic nuclei (Fig- 
ures 4B and 4C), a diagonal band of Broca (Figures 4B 
and 4D), the olfactory bulb, and in deep cerebellar nuclei 
and regions of the midbrain (Figure 4B). A narrow band of 
HPrP-res immunostaining was also observed in the middle 
cortical layers of the cerebral cortex (Figure 48), which was 
atrophied in 50% of Tg52NSE mice infected with hamster 
scrapie. There was no detectable HPrP-res staining in the 
basal ganglia, hippocampus, or cerebellar cortex. Unin- 
fected Tg52NSE mice showed no HPrP immunoreactivity 
in brain parenchyma and only weak, nonspecific immu- 
noreactivity in the choroid plexus and glial limitans (Fig- 
ure 4A). 
The HPrP-res immunoreactivity in the brains of hamster 
scrapie- infected Tg52NSE mice had either a diffuse or 
focal, plaque-like staining pattern. In several brain regions, 
HPrP-res was located in, or adjacent to, neuronal peri- 
karya. For example,  perineuronal HPrP-res staining in the 
anterior hypothalamic area completely encircled individ- 
ual neurons (Figure 4E, arrows). A "beads-on-a-string" 
HPrP-res staining pattern (Figure 4E, arrowheads) also 
was observed, and these linear structures had a narrow 
width but could be as long as 120 p.m. This pattern was 
reminiscent of axonal staining, although we could not de- 
finitively associate this distribution with nerve cell bodies. 
However, in the midbrain, HPrP-res staining appeared to 
be located in the perikaryon and proximal axon of individ- 
ual neurons (Figure 4F). 
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Discussion 
Previous transgenic mice expressing HPrP were made 
using a 40 kb cosmid clone containing the HPrP gene 
(Scott et al., 1989; Prusiner et al., 1990). Because of the 
large amount of DNA in these transgenes, it was not possi- 
ble to prove that HPrP expression was the only genetic 
factor involved in the induction of susceptibility to hamster 
scrapie in these mice. Furthermore, earlier attempts to 
produce transgenic mice using only the HPrP open read- 
ing frame were not successful (Scott et al., 1989). In con- 
trast, the present experiments ucceeded in getting high 
levels of HPrP expression by using a transgene containing 
only 1 kb of hamster DNA including the 762 base pair open 
reading frame of HPrP together with the neuron-specific 
enolase promoter. Thus, the high susceptibility of Tg52NSE 
mice to hamster scrapie demonstrates that this HPrP mini- 
gene including the open reading frame itself is the critical 
element in inducing susceptibility to the hamster scrapie 
agent in vivo. 
In the present work, we have studied only one NSE- 
HPrP transgenic mouse line, Tg52NSE. Therefore, it is 
conceivable that the susceptibility of this line to hamster 
scrapie might be a result of site-specific disruption of the 
function of a normal mouse gene, rather than expression 
of the HPrP trangene. However, this is highly unlikely since 
several transgenic mouse lines expressing HPrP with the 
PrP promoter have been studied (see Figure 3) (Scott et 
al., 1989; Prusiner et al., 1990), and in all cases HPrP 
expression level correlates with susceptibility to hamster 
scrapie. Thus, the HPrP expression level, rather than dis- 
ruption of an unknown mouse gene, appears to be the 
critical factor in abrogating the species barrier in this 
system. 
Neuron-specific expression mediated by the NSE pro- 
motor has previously been found in several other 
transgenic mouse models (Forss-Petter et al., 1990; 
Mucke et al., 1994; Rail et al., 1995). In the present report, 
neuron-specific HPrP expression was demonstrated by 
both in vivo and in vitro experiments and was sufficient 
to render mice susceptible to CNS disease induced by 
the 263K hamster scrapie strain. Several previous reports 
indicate that astrocytes and splenic follicular dendritic 
cells (FDC) may be the earliest sites of PrP-res accumula- 
tion following scrapie infection (Diedrich et al., 1991 ; Mura- 
moto et al., 1993; Moser et al., 1995), and these sites 
might also be important in restriction of agent replication 
following interspecies transmission of TSE agents (Mura- 
moto et al., 1993). However, based on the present findings, 
HPrP expression in astrocytes or FDC was not required to 
mediate susceptibility of mice to intracerebral inoculation 
with hamster scrapie. Nevertheless, in addition to neu- 
rons, HPrP expression in cells such as astrocytes, FDC, 
or even other cell types might also be sufficient to over- 
come the scrapie species barrier, and FDC in spleen and 
lymph nodes m ight be particularly involved in interspecies 
transmission following intraperitoneal inoculation of 
agent. 
Based on recent results involving cell-free interactions 
between PrP-sen and PrP-res from mouse and hamster 
(Kocisko et al., 1994, 1995), it seems likely that the species 
specificity of TSE agents involves direct interactions be- 
tween PrP molecules, which either facilitate or inhibit the 
process of PrP-res generation in vivo. For example, incu- 
bation of mouse PrP-res with hamster PrP-sen or mouse 
PrP-sen resulted in generation of protease-resistant prod- 
ucts with differing subunit molecular weights (Kocisko et 
al., 1995). This suggested that the biochemical structures 
of the intact protease-resistant PrP forms were not identi- 
cal when PrP-sen from different species were used. Such 
structural differences might be involved in the species- 
specific adaptation that often occurs following interspe- 
cies transmission of TSE agents. 
In contrast to the present and previous (Scott et al., 
1989; Prusiner et al., 1990) data with transgenic mice, we 
have not been successful in infecting mouse neuro- 
blastoma cells in vitro with hamster scrapie, even when 
clones expressing high levels of HPrP were utilized (Priola 
et al., 1994). In mouse neuroblastoma cells infected with 
mouse scrapie, the expression of hamster PrP interfered 
with generation of mouse PrP-res (Priola et al., 1994), and 
by analogy similar interactions may also be capable of 
blocking exogenous infection by the hamster scrapie 
agent in these cell lines. Although in the present experi- 
ments inhibitory effects of HPrP expression on infection 
of Tg52NSE mice with mouse scrapie resulted in a signifi- 
cantly increased incubation period, all mice eventually de- 
veloped clinical disease. In the converse experiment of 
infection of Tg52NSE by hamster scrapie agent, the incu- 
bation period was longer than in normal hamster (Table 
1), but again all mice were susceptible. At present, we 
have no adequate explanation for the differences in inter- 
species infection experiments between in vitro mouse neu- 
roblastoma cell lines and transgenic mice in vivo; however, 
one important factor might be that the mice are 100,000- 
fold more sensitive to scrapie infection than are mouse 
neuroblastoma cells (Race et al., 1988; Race and Ernst, 
1992). 
The present results indicated that some sites of high 
HPrP-sen expression in Tg52NSE mice, such as cerebel- 
lar cortex and hippocampus, had no detectable HPrP-res 
deposition. Thus, factors other than level of HPrP-sen ex- 
pression can also influence HPrP-res accumulation. Such 
factors might include foreign PrP molecules and cellular 
glycosaminoglycans, both of which have been noted to 
influence the biochemistry of PrP-res generation in vitro 
(Caughey and Raymond, 1993; Caughey et al., 1994; Pri- 
ola et al., 1994). These same factors might also account 
for the difference in clinical course and in sites of PrP-res 
deposition between Tg52NSE mice and normal hamsters 
after infection with hamster scrapie strain 263K. In addi- 
tion, non-PrP genetic differences involving major histo- 
compatibility complex genes (Kingsbury et al., 1983; Carp 
and Callahan, 1986) or other genes (Carlson et al., 1988; 
Race et al., 1990; Westaway et al., 1991) might also influ- 
ence patterns of both PrP-res deposition and clinical dis- 
ease following interspecies TSE agent transmission. 
Although experiments with PrP transgenic mice have 
provided helpful insights into the importance of PrP in 
scrapie pathogenesis and interspecies transmission, it is 
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possible that some phenomena observed in transgenic 
mice are the result of abnormal  overexpress ion of PrP. 
For example,  some transgenic mice expressing mouse or 
nonmouse PrP have developed a spontaneous degenera- 
tive brain d isease in the absence of scrapie infection 
(Hsiao et al., 1990; Westaway et al., 1994). In other in- 
stances, transgenic mice expressing an MPrP gene asso- 
ciated with resistance to most  mouse scrapie strains had 
increased sensitivity to mouse scrapie (Westaway et al., 
1991). Both of these unexpected examples  of neurode- 
generat ive disease in PrP transgenic mice are believed to 
involve overexpress ion of PrP, but the detai led pathogenic 
mechanisms involved in each are not known. Thus, it will 
be important in the future to confirm conclusions derived 
from transgenic mice by using PrP null mice, where the 
mouse PrP gene can be replaced in its normal context  in 
the mouse genome by a single copy of a mutant  or foreign 
PrP gene. 
Experimental Procedures 
Generation of Transgenic Mice 
A 1.0 kb fragment of hamster PrP cDNA containing the 762 bp open 
reading frame plus 54 bp of upstream sequence and 175 bp of down- 
stream sequence was obtained by digestion with EcoRl and Hindlll 
from pEA974 provided by Dr. N. Robakis (Robakis et al., 1986a, 
1986b). After blunting DNA ends with Klenow enzyme, Xhol linkers 
were added and the fragment was subcloned in pBluescript-KS+ to 
generate p2-17. This clone was digested with Kpnl, ends were blunted 
with Klenow enzyme, and a Hindlll linker was inserted. Subsequently, 
the Sail site in the polylinkers was eliminated by Sail digestion, blunting 
with Klenow, and religation. A 1.0 kb HPrP fragment was then excised 
from this clone with Hindlll and inserted into the unique Hindlll site 
of pNSE-Ex 4, which was provided by Dr. Sonja Forss-Petter, Scripps 
Research Institute (Forss-Petter et al., 1990; Mucke et al., 1994). This 
plasmid was then digested with Sail to remove the pUC 19 vector 
sequences to produce the purified DNA fragment shown in Figure 1A, 
which was used to generate Tg52NSE transgenic mice. 
The 40 kb cosmid described by Scott et al. (1989) was kindly pro- 
vided by Dr. Stanley Prusiner and was used to generate Tgl0 mice. 
Analysis of Transgenic Mouse DNA 
Tail DNA isolated as described (Race et al., 1990) was analyzed by 
slot blot hybridization using standard techniques with an HPrP cDNA 
probe (Oesch et al., 1985) or by polymerase chain reaction (PCR). 
Transgenic mice were identified as those having signal intensity 
greater than that of non-Tg littermates. To estimate HPrP copy number, 
successive 10-fold DNA dilutions were blotted, hybridized, and com- 
pared to nontransgenic mouse or hamster DNA similarly diluted. Alter- 
natively, a hamster-specific PrP polymerase chain reaction (PCR) 
assay was utilized. The upper strand primer (5'AACCGTTACCCACCT- 
CAGGGT 3') did not distinguish mouse PrP from hamster PrP; how- 
ever, the lower strand primer (3'ATGGTGGGTCATAGTCTTCCTC 5') 
contained four base differences (underlined) between mouse and ham- 
ster PrP. PCR was done using 50-500 ng of DNA in 25 p.I volume 
with standard buffers. The first cycle was 95°C for 5 min, 50°C for 
30 sec and 72°C for 1 min. This was followed by 29 cycles of 95°C 
for 1 min, 50°C for 30 sec, and 72°C for 1 min. Using normal hamster 
or HPrP Tg mouse DNA as the template, this assay gave a 530 kb 
DNA band detectable by ethidium bromide staining. No band was seen 
when normal mouse DNA was used. 
Northern Blots 
Polyadenylated mRNA was isolated using the Invitrogen Micro-Fast 
Track mRNA isolation kit according to the manufacturers instructions. 
Polyadenylated mRNA was electrophoresed in 6% formaldehyde, 
1.4o/0 agarose gels, blotted onto Nylon-1 membrane (GIBCO BRL), 
and baked 2 hr at 80°C. The membranes were hybridized as described 
(Caughey et al., 1988). The probe was the same as for slot blot analysis. 
In Situ Hybridization 
In situ hybridization was performed as described previously (Borrow 
et al., 1995). Briefly, a 3sS-labeled single-stranded RNA probe specific 
for the SV40 sequence was used to detect expression in sections of 
brain. Two hundred seventeen bases of SV40 sequence were cloned 
into the pSP70 plasmid (Promega). The plasmid was linearized by 
Bglll digestion, and a product complementary to the SV40 mRNA was 
transcribed by the Sp6 polymerase. The quantity of probe generated 
was calculated by measuring the percentage incorporation of the radio- 
isotope. Paraffin-embedded sections from saline-perfused tissue fixed 
in Bouins or 10% formalin were deparaffinized by washing twice for 
5 min in xylene and twice for 5 min in 100% ethanol. The sections 
were treated, hybridized, and developed as described (Borrow et al., 
1995), with the exception that the hybridization temperature was 55°C. 
Western Blots 
Immunoblotting was used to detect HPrP-sen and HPrP-res in tissues 
of hamsters and transgenic and normal mice. For PrP-sen, 20% brain 
homogenates were made in disposable tube and pestle (Kontes, Vine- 
land, New Jersey) in ice-cold 0.32 M sucrose containing 0.1 I~M leupeptin, 
0.15 p.M apoprotinin, 0.1 ~M pepstatin, and 0.001 M phenylmethylsulfo- 
nylfluoride (PMSF). The homogenate was sonicated for 2 min then micro- 
fuged at 10,000 g for 10 min. Supernatant fluid was carefully removed 
and added to an equal volume of 2x sample buffer. This solution was 
vortexed, boiled 5 min and frozen until immunoblots could be run. 
PrP-res was isolated from brain as previously described, except 
brain homogenates were made in disposable tube and pestle (Race 
and Ernst, 1992). Final pellets were suspended by sonication in sample 
buffer at a concentration of 3 mg/p.I. HPrP-sen or HPrP-res proteins 
were separated on 15% polyacrylamide gels as described (Race and 
Ernst, 1992), and proteins were detected using a 1:20,000 dilution of 
ascites containing hamster-specific monoclonal antibody 3F4 (Kasc- 
sak et al., 1987), with the Enhanced Chemiluminescence procedure 
according to the manufacturers instructions (Amersham, Buckingham- 
shire, England). 
HPrP Expression in Cultured Cells 
Astrocytes were prepared from 2 day-old mice as described (Rail et 
al., 1994). Briefly, brains were removed, and cells were mechanically 
dissociated and cultured on poly-L-lysine-coated culture flasks. Two 
days after culturing, the cells were extensively washed to remove de- 
bris and shaken overnight at 100 rpm to remove nonastroglial cells 
(microglia). The cultures were then trypsinized and plated onto glass 
cover slips for immunostaining. Primary hippocampal neurons were 
plated as described (Pasick et al., 1994). Briefly, hippocampi were 
dissected from the brains of embryos 15-17 clays old, trypsinized and 
triturated, and cultured on poly-L-lysine-coated glass cover slips at a 
density of 500 cells/mm 2. Of these cells, 92%-95% are routinely posi- 
tive for MAP2, a neuronal marker. For immunostaining, cultures were 
exposed to a 1:200 dilution of MAb 3F4 ascites fluid for 2 hr at 37°C. 
After gentle washing, cells were fixed in 50% acetone/50% methanol 
for 10 min, then washed extensively with buffer and reacted with biotin- 
ylated antimouse secondary antibody (Mouse Elite, Vector Labora- 
tories, Burlingame, VT). Following a 1 hr incubation with secondary 
antibody, the cells were washed, reacted with the avidin-biotin reagent, 
and incubated with hydrogen peroxide plus diaminobenzidene chro- 
mogen, resulting in a brown precipitate over positive cells. 
Immunohistochemistry 
Brains from clinically ill, age-matched mice were perfused with Bouin's 
fixative or 10% formaldehyde followed by immersion fixation. Paraffin- 
embedded sections of brain were submersed in 1.0 mM HCI and auto- 
claved for 10 min (Kitamoto et al., 1992). Immunostaining for brain 
HPrP-res was performed using mouse monoclonal antibody 3F4 (Kasc- 
sak et al., 1987). Briefly, after blocking, tissue was incubated with 3F4 
antibody diluted 1 ;2,000 in 3% bovine serum albumen in Tris-buffered 
saline (pH 7.4) for 2 hr at 37°C. Tissue sections were washed and 
incubated with goat antimouse IgG (1:250, Bio-Rad Laboratories, Her- 
cules, CA.) conjugated with horseradish peroxidase for 1 hr at room 
temperature. Color development was performed with 0.8 mg/ml of 
3-amino-9-ethylcarbazole in 50 mM sodium acetate (pH 5.0) and 
0.03% water. Tissue sections were counterstained with Mayer's hema- 
toxylin. MAb 3F4 detects hamster PrP but not mouse PrP (Kascsak 
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et al., 1987). The hydrolytic autoclaving procedure is specific for PrP- 
res and does not detect PrP-sen. 
Scrapie Infection of Animals 
Tg52NSE, Tgl0 and non-Tg mice and hamsters were inoculated with 
either 263K strain of hamster scrapie agent (Marsh and Kimberlin, 
1975) or the Chandler strain of mouse scrapie agent (Eklund et al., 
1967). Mice received 10 e LD50 of hamster agent or 10 ~ LD50 mouse 
scrapie agent intracerebrally in a volume of 50 ~1. 
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